Inovio Pharmaceuticals (INO) EBITDA Margin (2009 - 2026)
Inovio Pharmaceuticals (INO) recorded EBITDA Margin of -130701.36% in FY2025, down 79911.06 percentage points from -50790.30% in FY2024.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) EBITDA Margin (2009 - 2026) Analysis & Trends
Starting with FY2009, Inovio Pharmaceuticals' EBITDA Margin history includes 17 years.
- Annual EBITDA Margin has declined for three straight years, with a five-year change of -129075.50 percentage points (FY2020 to FY2025).
- The FY2025 figure is the lowest annual EBITDA Margin in data going back to FY2009.
- Per Business Quant data, INO's EBITDA Margin was -50790.30% in FY2024 (-33822.60 pp), -16967.70% in FY2023 (-14401.24 pp), -2566.46% in FY2022 (+14205.26 pp) and -16771.72% in FY2021 (-15145.86 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Inovio Pharmaceuticals | 143.02 Mn | -38.21 Mn | - | -6,424.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -6,424.50% |
| Mar 31, 2025 | -37,768.64% |
| Dec 31, 2024 | -17,013.60% |
| Jun 30, 2024 | -32,458.04% |
| Dec 31, 2023 | -26,131.31% |
| Sep 30, 2023 | -8,987.53% |
| Jun 30, 2023 | -16,052.72% |
| Mar 31, 2023 | -37,551.41% |
| Dec 31, 2022 | -44,040.27% |
| Sep 30, 2022 | -379.40% |
| Jun 30, 2022 | -13,139.52% |
| Mar 31, 2022 | -35,502.68% |
| Dec 31, 2021 | -12,446.06% |
| Sep 30, 2021 | -20,258.23% |
| Jun 30, 2021 | -30,192.01% |
| Mar 31, 2021 | -13,946.11% |
| Dec 31, 2020 | -510.47% |
| Sep 30, 2020 | -15,021.30% |
| Jun 30, 2020 | -12,068.48% |
| Mar 31, 2020 | -1,829.74% |
API Access
Inovio Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();